Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis

Rheumatology

Volumn 40, Issue 3, 2001, Pages 310-314

  La Montagna, G ^a   Baruffo, A ^a   Pasquali, D ^a   Bellastella, A ^a   Tirri, G ^a   Sinisi, A A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Gonadotropins; Prolactin; Systemic Sclerosis

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; GRISEOFULVIN; HYDROXYCHLOROQUINE; LUTEINIZING HORMONE; PENICILLAMINE; PROLACTIN; THYROTROPIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGONADISM; LUNG DISEASE; ORGAN; PERIPHERAL VASCULAR DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROVOCATION TEST; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; REPRODUCTION; SYSTEMIC SCLEROSIS;

ADULT; AGE FACTORS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MIDDLE AGED; POSTMENOPAUSE; PROLACTIN; SCLERODERMA, SYSTEMIC; THYROTROPIN;

EID: 0035060877     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Scleroderma
2. Pregnancy in women with systemic sclerosis
3. Pregnancy and systemic sclerosis
4. Reproductive function prior to disease onset in women with scleroderma
5. Fertility and pregnancy outcome in women with systemic sclerosis
6. Scleroderma of uterine cervix
7. High serum level of prolactin in patients with systemic sclerosis
8. High prolactin and low dehydro-epiandrosterone sulphate serum levels in patients with severe systemic sclerosis
9. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus?
10. Preliminary criteria for classification of systemic sclerosis (scleroderma)
11. Scleroderma (systemic sclerosis). Classification, subsets and pathogenesis
12. A disease severity scale for systemic sclerosis: Development and testing
13. The pituitary
14. Thyroid disorders in patients with progressive systemic sclerosis
15. Thyroid function in systemic sclerosis
16. Influence of dopamine on the altered release of prolactin, luteinizing hormone and follicle-stimulating hormone induced by interleukin and in vitro
17. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus
18. The syntax of immune-neuroendocrine communication
19. Prolactin, immunoregulation and autoimmune diseases
20. Growth hormone and prolactin are paracrine growth and differentiation factors in the haematopoietic system
21. Autoantibody profile in the sera of women with hyperprolactinemia
22. Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity
23. Prolactin influences autoimmune disease activity in the female B/W mouse
24. Neuroendocrine immune systems interactions and autoimmunity
25. Soluble serum IL2 receptors in patients with systemic sclerosis
26. Interaction between the immune and endocrine systems: Immunomodulatory effects of luteinizing hormone
27. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro
28. FSH and LH induce interleukin 6 (IL-6) release from human peripheral blood monocytes culture in vitro. A dose response study
29. Prolactin deficiency in rheumatoid arthritis
30. Prolactin in systemic lupus erythematosus